Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma

Patients with colorectal cancer in different stages show variable outcomes/therapeutic responses due to their distinct tumoral biomarkers and biological features. In this sense, this study aimed to explore the prognostic utility of BRAF, programmed death-1 (PD1), and its ligand (PDL1) protein signat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahiem, Afaf T., Eladl, Entsar, Toraih, Eman A., Fawzy, Manal S., Abdelwahab, Khaled, Elnaghi, Khaled, Emarah, Ziad, Shaalan, Aly A. M., Ehab, Ziad, Soliman, Nahed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858159/
https://www.ncbi.nlm.nih.gov/pubmed/36673047
http://dx.doi.org/10.3390/diagnostics13020237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858159/
https://www.ncbi.nlm.nih.gov/pubmed/36673047
http://dx.doi.org/10.3390/diagnostics13020237

Ejemplares similares